Psoriasis is an immune-mediated chronic skin condition that also has effects on other systems of the body and is associated with several other debilitating conditions, such as diabetes, heart disease, and mental disorders. Psoriasis represents a huge healthcare burden, and afflicted patients report high economic costs and a poor quality of life. An improved understanding of the pathophysiology of the disease has led to the development and approval of several novel therapies, and the treatment landscape has been constantly evolving. Given that new evidence continues to be reported and that therapy recommendations keep changing, it is paramount that dermatologists and other healthcare clinicians are up-to-date on recent safety and efficacy outcomes and are able to provide individualized care for diverse patients with complex comorbid conditions. Current clinical practice, however, has been lagging behind, and many clinicians face challenges in effectively employing multidisciplinary and patient-centered approaches to improving patient outcomes.
April W. Armstrong, MD, MPH Professor of Dermatology Associate Dean of Clinical Research Director, Psoriasis Program University of Southern California Los Angeles, California
Purdue College of Pharmacy is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Purdue College of Pharmacy designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Co-provided by Purdue College of Pharmacy and Integrity Continuing Education, Inc.
This activity is supported by an educational grant from Novo Nordisk.
